Thursday, April 07, 2016 11:12:37 AM
Recent VKTX News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 11:31:16 AM
- Viking Therapeutics Reports New Data from VK2735 Obesity Program at ObesityWeek® 2024 • PR Newswire (US) • 11/04/2024 11:30:00 AM
- Tesla Sales Drop; Intel to Exit Dow Jones After 25 Years; VKTX and ATSG Surge Over 20% Pre-Market • IH Market News • 11/04/2024 11:20:51 AM
- Viking Therapeutics to Participate at Upcoming Investor Conferences • PR Newswire (US) • 10/31/2024 08:05:00 PM
- Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek® 2024 • PR Newswire (US) • 10/28/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/25/2024 11:28:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/25/2024 08:10:16 PM
- Tesla Shares Rise 11% Pre-Market; IBM Falls 4% on Lower-Than-Expected Revenue; Apple Prepares New Launches • IH Market News • 10/24/2024 10:07:47 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/23/2024 09:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2024 08:09:55 PM
- Viking Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update • PR Newswire (US) • 10/23/2024 08:05:00 PM
- US Futures Fall Amid Treasury Yield Surge and Earnings; Oil Prices Dip as U.S. Crude Inventories Rise • IH Market News • 10/23/2024 09:58:27 AM
- Viking Therapeutics to Report Financial Results for Third Quarter 2024 on October 23, 2024 • PR Newswire (US) • 10/16/2024 08:05:00 PM
- Tesla’s Robotaxi Day; GSK Settles 93% of Zantac Lawsuits; 10x Genomics Stock Drops on Revenue Forecast • IH Market News • 10/10/2024 10:45:48 AM
- Viking Therapeutics Announces Results from Phase 1b Clinical Trial of VK0214 in Patients with X-ALD • PR Newswire (US) • 10/09/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/21/2024 01:20:57 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/20/2024 08:29:51 PM
- Viking Therapeutics to Participate at Morgan Stanley 22nd Annual Global Healthcare Conference • PR Newswire (US) • 08/28/2024 08:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 11:23:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/21/2024 08:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 12:13:31 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/20/2024 12:00:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/31/2024 08:05:07 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM